Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. (“Tokai” or the “Company”) (NASDAQ:TKAI) and...
-
SAN FRANCISCO, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the Northern District of California has approved the following announcement of a...
-
NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Insmed Incorporated (“Insmed” or the “Company”) (NASDAQ:INSM) and certain...
-
NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lipocine Inc. (“Lipocine” or the “Company”) (NASDAQ:LPCN), and certain of the...
-
NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CytRx Corporation (“CytRx” or the “Company”) (NASDAQ:CYTR) and certain of its...
-
NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Niantic, Inc. (“Niantic”), The Pokémon Company (“Pokémon Co.”), and Nintendo...
-
NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP reminds all investors who purchased shares in Groupon’s initial public offering, or between November 4, 2011 and March 30, 2012, that the...
-
NEW YORK, July 29, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Juno Therapeutics, Inc. (“Juno” or the “Company”) (NASDAQ:JUNO) and certain...
-
NEW YORK, July 24, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Chiasma, Inc. (“Chiasma” or the “Company”) (NASDAQ:CHMA) and certain of its...
-
NEW YORK, July 24, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Immunomedics, Inc. (“Immunomedics” or the “Company”) (NASDAQ:IMMU) and...